197 related articles for article (PubMed ID: 24896622)
1. A novel biological target for the treatment of psoriatic arthritis.
Spadaro A; Montepaone M; Lubrano E
Immunotherapy; 2014; 6(5):515-8. PubMed ID: 24896622
[TBL] [Abstract][Full Text] [Related]
2. Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials.
Kavanaugh A; Ritchlin C; Rahman P; Puig L; Gottlieb AB; Li S; Wang Y; Noonan L; Brodmerkel C; Song M; Mendelsohn AM; McInnes IB;
Ann Rheum Dis; 2014 Jun; 73(6):1000-6. PubMed ID: 24553909
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial.
Ritchlin C; Rahman P; Kavanaugh A; McInnes IB; Puig L; Li S; Wang Y; Shen YK; Doyle MK; Mendelsohn AM; Gottlieb AB;
Ann Rheum Dis; 2014 Jun; 73(6):990-9. PubMed ID: 24482301
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of ustekinumab in biologic-naïve patients with psoriatic arthritis by prior treatment exposure and disease duration: data from PSUMMIT 1 and PSUMMIT 2.
McInnes IB; Chakravarty SD; Apaolaza I; Kafka S; Hsia EC; You Y; Kavanaugh A
RMD Open; 2019; 5(2):e000990. PubMed ID: 31565242
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis.
Eder L; Thavaneswaran A; Chandran V; Gladman DD
Ann Rheum Dis; 2014 Jun; 73(6):1007-11. PubMed ID: 23619157
[TBL] [Abstract][Full Text] [Related]
6. Radiographic Progression Inhibition with Intravenous Golimumab in Psoriatic Arthritis: Week 24 Results of a Phase III, Randomized, Double-blind, Placebo-controlled Trial.
Kavanaugh A; Husni ME; Harrison DD; Kim L; Lo KH; Noonan L; Hsia EC
J Rheumatol; 2019 Jun; 46(6):595-602. PubMed ID: 30770519
[TBL] [Abstract][Full Text] [Related]
7. A review of ustekinumab in the treatment of psoriatic arthritis.
Roberts J; O'Rielly DD; Rahman P
Immunotherapy; 2018 Apr; 10(5):361-372. PubMed ID: 29439608
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2).
Kavanaugh A; Puig L; Gottlieb AB; Ritchlin C; You Y; Li S; Song M; Randazzo B; Rahman P; McInnes IB
Ann Rheum Dis; 2016 Nov; 75(11):1984-1988. PubMed ID: 27098404
[TBL] [Abstract][Full Text] [Related]
9. Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial.
Kavanaugh A; van der Heijde D; McInnes IB; Mease P; Krueger GG; Gladman DD; Gómez-Reino J; Papp K; Baratelle A; Xu W; Mudivarthy S; Mack M; Rahman MU; Xu Z; Zrubek J; Beutler A
Arthritis Rheum; 2012 Aug; 64(8):2504-17. PubMed ID: 22378566
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial.
McInnes IB; Kavanaugh A; Gottlieb AB; Puig L; Rahman P; Ritchlin C; Brodmerkel C; Li S; Wang Y; Mendelsohn AM; Doyle MK;
Lancet; 2013 Aug; 382(9894):780-9. PubMed ID: 23769296
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study.
Kavanaugh A; McInnes IB; Mease PJ; Krueger GG; Gladman DD; van der Heijde D; Mudivarthy S; Xu W; Mack M; Xu Z; Beutler A
Ann Rheum Dis; 2013 Nov; 72(11):1777-85. PubMed ID: 23161902
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity.
Landewé R; Ritchlin CT; Aletaha D; Zhang Y; Ganz F; Hojnik M; Coates LC
Rheumatology (Oxford); 2019 Jun; 58(6):1025-1033. PubMed ID: 30608620
[TBL] [Abstract][Full Text] [Related]
13. Therapy: Ustekinumab after anti-TNF failure: a step closer to the PSUMMIT of psoriatic arthritis therapy?
Onuora S
Nat Rev Rheumatol; 2014 Mar; 10(3):125. PubMed ID: 24535545
[No Abstract] [Full Text] [Related]
14. Psoriatic Arthritis Mutilans: Characteristics and Natural Radiographic History.
Jadon DR; Shaddick G; Tillett W; Korendowych E; Robinson G; Waldron N; Cavill C; McHugh NJ
J Rheumatol; 2015 Jul; 42(7):1169-76. PubMed ID: 25979723
[TBL] [Abstract][Full Text] [Related]
15. The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year.
Kavanaugh A; Antoni CE; Gladman D; Wassenberg S; Zhou B; Beutler A; Keenan G; Burmester G; Furst DE; Weisman MH; Kalden JR; Smolen J; van der Heijde D
Ann Rheum Dis; 2006 Aug; 65(8):1038-43. PubMed ID: 16439444
[TBL] [Abstract][Full Text] [Related]
16. Ustekinumab: a review of its use in psoriatic arthritis.
McKeage K
Drugs; 2014 Jun; 74(9):1029-39. PubMed ID: 24919864
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of tocilizumab in a patient with refractory psoriatic arthritis.
Costa L; Caso F; Cantarini L; Del Puente A; Scarpa R; Atteno M
Clin Rheumatol; 2014 Sep; 33(9):1355-7. PubMed ID: 24705820
[TBL] [Abstract][Full Text] [Related]
18. Ustekinumab for the treatment of psoriasis and psoriatic arthritis: a drug evaluation and literature review.
Thibodaux RJ; Triche MW; Espinoza LR
Expert Opin Biol Ther; 2018 Jul; 18(7):821-827. PubMed ID: 29949399
[TBL] [Abstract][Full Text] [Related]
19. Ustekinumab : targeting the IL-17 pathway to improve outcomes in psoriatic arthritis.
Weitz JE; Ritchlin CT
Expert Opin Biol Ther; 2014 Apr; 14(4):515-26. PubMed ID: 24555741
[TBL] [Abstract][Full Text] [Related]
20. Ustekinumab: The "New Kid on the Block" in the Treatment of Psoriatic Arthritis.
Torres T; Faria R
Drug Dev Res; 2015 Dec; 76(8):428-31. PubMed ID: 26372543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
